SeaSpine Holdings Corporation Stock News

Based on preliminary estimates, SeaSpine (SPNE) expects Q421 global revenue in the range of $55.1M to $55.5M (vs. consensus of $54.46M)

SeaSpine (NASDAQ:SPNE) had its target price cut by Truist Securities from $25.00 to $20.00 in a report issued on Tuesday, Analyst Price Targets reports. They currently have a buy rating on the medical equipment providers stock. A number of other equities research analysts have also recently commented on the stock. TheStreet cut shares of SeaSpine [] The post Truist Securities Cuts SeaSpine (NASDAQ:SPNE) Price Target to $20.00 appeared first on ETF Daily News .

SeaSpine Holdings Co. (NASDAQ:SPNE) Investment analysts at Truist Securiti issued their FY2023 earnings per share (EPS) estimates for SeaSpine in a research note issued to investors on Tuesday, December 21st. Truist Securiti analyst S. Brodovsky forecasts that the medical equipment provider will post earnings of ($0.78) per share for the year. Several other research [] The post Brokers Set Expectations for SeaSpine Holdings Co.s FY2023 Earnings (NASDAQ:SPNE) appeared first on ETF Daily News .

SeaSpine (NASDAQ:SPNE) had its price objective reduced by equities research analysts at Truist Securities from $25.00 to $20.00 in a report released on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the medical equipment providers stock. Truist Securities target price suggests a potential upside of 63.40% from the stocks previous close. Several []

CARLSBAD, Calif., Dec. 14, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disord

CARLSBAD, Calif., Dec. 14, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has appointed Angela Steinway to its Board of Directors, effective December 14, 2021. Ms. Steinway will serve as a member of the companys Audit Committee. With the appointment of Ms. Steinway, the SeaSpine Board of Directors now consists of nine directors, eight of whom are independent.

Analysts forecast that SeaSpine Holdings Co. (NASDAQ:SPNE) will post earnings of ($0.33) per share for the current quarter, according to Zacks. Eight analysts have made estimates for SeaSpine’s earnings, with estimates ranging from ($0.55) to ($0.18). SeaSpine posted earnings per share of ($0.37) during the same quarter last year, which would indicate a positive year […]

TheStreet downgraded shares of SeaSpine (NASDAQ:SPNE) from a c- rating to a d+ rating in a report published on Tuesday, TheStreetRatingsTable reports. Several other brokerages have also issued reports on SPNE. Loop Capital began coverage on SeaSpine in a research note on Thursday, October 28th. They issued a buy rating and a $100.00 price target []

SeaSpine (NASDAQ:SPNE) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Profitability This table compares SeaSpine and Femasys net margins, return on equity and return on assets. Net [] The post Financial Analysis: SeaSpine (NASDAQ:SPNE) vs. Femasys (NASDAQ:FEMY) appeared first on ETF Daily News .

SeaSpine's (SPNE) next-generation Admiral ACP System covers the largest segment in the estimated $1.30-billion cervical spine surgery market.

CARLSBAD, Calif., Nov. 23, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disor

CARLSBAD, Calif., Nov. 23, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of its Admiral ACP System. Admiral ACP represents the next generation of anterior cervical plating and was designed to strike the optimal balance between strength, profile and construct rigidity. Differentiated plate features, combined with step-eliminating innovative instrumentation, work seamlessly in the surgeons hands to create a more efficient and consistent anterior cervical discectomy and fusion (ACDF) experience.

The Spinal Posterior Fixation System Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts

SeaSpine (NASDAQ:SPNE) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, institutional ownership, profitability and earnings. Risk & Volatility SeaSpine has a beta of 1.12, meaning that its share price is []